| LY2801653 |
梅沙替尼 |
1206799-15-6 |
| Brigatinib |
布格替尼 |
1197953-54-0 |
| N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonaMide |
达拉菲尼中间体5 |
1195768-23-0 |
| N-(3-(2-(2-chloropyriMidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonaMide |
达拉非尼杂质1 |
1195768-20-7 |
| Dabrafenib Mesylate(GSK-2118436B) |
达帕菲尼甲磺酸盐 |
1195768-06-9 |
| Methyl 3-{[(2,6-difluoropheyl)sulfonyl]aMino}-2-fluorabenzoate |
达拉菲尼中间体3 |
1195768-19-4 |
| Dabrafenib |
达拉非尼 |
1195765-45-7 |
| Lawesson's Reagent |
劳森试剂 |
19172-47-5 |
| Lorlatinib (PF-06463922) |
劳拉替尼 |
1454846-35-5 |
| tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate |
(4-溴-5-氰基-1-甲基-1H-吡唑-3-基)甲基甲基氨基甲酸叔丁酯 |
1454848-24-8 |
| 2-Chloro-4-methylpyrimidine |
2-氯-4-甲基嘧啶 |
13036-57-2 |
QQ
微信
